Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience.

Andrea MatucciEmanuele VivarelliMargherita PerlatoValentina MecheriMatteo AccinnoLorenzo CosmiPaola ParronchiOliviero RossiAlessandra Vultaggio

Published in: Biomedicines (2022)

Eosinophils in EGPA are an important biomarker and are associated with extrapulmonary involvement. These findings could strengthen the role of anti-eosinophilic drugs in improving extrapulmonary disease.

Keyphrases

risk assessment
peripheral blood
human health
chronic rhinosinusitis